US2003180346A1PendingUtilityA1
Silver containing wound dressing
Priority: Sep 21, 2000Filed: Sep 21, 2001Published: Sep 25, 2003
Est. expirySep 21, 2020(expired)· nominal 20-yr term from priority
Inventors:David Malcolm Woods
Y10T442/655A61L 2300/104A61L 15/18A61L 2300/404Y10T442/475Y10T428/24993Y10T442/481A61L 2300/42Y10T442/2525A61L 26/0052A61L 15/28Y10T428/24041A61L 26/0023A61L 15/46A61L 26/0066A61L 15/44
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A wound dressing having anti-microbial activity comprises a first fibre capable of bonding with silver ( 1 ) cations. The wound dressing comprises a blend of the first fibre to which silver ( 1 ) cations are bonded and a second fibre which is substantially free from silver. The wound dressing comprises from 0.01 to 5.0 percent by weight of silver ( 1 ) cations, based on the weight of fibre.
Claims
exact text as granted — not AI-modified1 . A wound dressing having anti-microbial activity, which wound dressing comprises a first fibre capable of bonding with silver ( 1 ) cations, characterised in that the wound dressing comprises a blend of the first fibre to which silver ( 1 ) cations are bonded and a second fibre which is substantially free from silver.
2 . A wound dressing according to claim 1 characterised in that it comprises from 0.01 to 5.0 percent by weight, of silver ( 1 ) cations based on the weight of fibre.
3 . A wound dressing according to claim 2 characterised in that it comprises from 0.1 to 4.0 percent by weight of silver ( 1 ) cations based on the weight of fibre.
4 . A wound dressing according to claim 3 characterised in that it comprises from 0.25 to 3.0 percent by weight of silver ( 1 ) cations based on the weight of fibre.
5 . A wound dressing according to any of claims 1 to 4 characterised in that the first fibre is substantially insoluble in water.
6 . A wound dressing according to any of claims 1 to 5 characterised in that the first fibre comprises a carboxymethylcellulose fibre, an alginate fibre, a chitosan or chitosan derivative fibre or an acrylic fibre.
7 . A wound dressing according to claim 6 characterised in that the first fibre is a carboxymethyl cellulose fibre and the wound dressing contains from 1.0 to 2.0% by weight of silver ( 1 ) cations, based on the weight of the fibre.
8 . A wound dressing according to claim 6 characterised in that the first fibre is an alginate fibre and the wound dressing contains from 0.25 to 0.75% by weight of silver ( 1 ) cations, based on the weight of the fibre.
9 . A wound dressing according to claim 6 or claim 7 characterised in that the first fibre is a carboxymethylcellulose fibre which has a degree of substitution between 0.1 and 0.4.
10 . A wound dressing according to claim 6 characterised in that the first fibre is an acrylic fibre which incorporates a comonomer to provide dye-sites in the fibre.
11 . A wound dressing according to claim 10 characterised in that the comonomer isitaconic acid or 2-acrylomido methyl propane sulphonic acid.
12 . A wound dressing according to any of claims 1 to 11 characterised in that the first fibre and the second fibre are similar.
13 . A wound dressing according to any of claims 1 to 12 characterised in that the ratio of the first fibre to the second fibre is in the range of from 0.5 to 25% by weight of the total weight of the fibre.
14 . A wound dressing according to claim 13 characterised in that the ratio of the first fibre to the second fibre is in the range of from 5 to 20% by weight of the total weight of the fibre.
15 . A wound dressing according to any of claims 1 to 10 characterised in that the first fibre includes about 10% by weight, based on the weight of fibre, of silver ( 1 ) cations.
16 . A wound dressing according to any of claims 1 to 12 characterised in that the silver ions are preferably chemically bonded to the first fibre.
17 . A wound dressing according to any of claims 9 to 14 characterised in that the first fibre is a carboxymethylcellulose fibre and the degree of substitution is in the range from 0.20 to 0.35.
18 . A wound dressing according to claim 14 characterised in that the degree of substitution is about 0.3.
19 . A wound dressing according to any of claims 1 to 15 characterised in that the silver ions are introduced into the first fibre by ion-exchange.
20 . A wound dressing according to any of claims 1 to 16 characterised in that the first fibre is a carboxymethylcellulose fibre and the carboxymethylcellulose is derived from lyocell.
21 . A wound dressing according to any of claims 1 to 17 characterised in that the fibrous carboxymethylcellulose is in the form of a staple fibre or continuous filament yarn.
22 . A wound dressing according to any one of the preceding claims characterised in that the carboxymethylcellulose is present in a needlepunched nonwoven textile.
23 . A wound dressing substantially as herein described and with reference to the Example 5.Join the waitlist — get patent alerts
Track US2003180346A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.